Actin requires the chaperonin containing TCP1 (CCT), a hexadecameric ATPase essential for cell viability in eukaryotes, to fold to its native state. Following binding of unfolded actin to CCT, the cavity of the chaperone closes and actin is folded and released in an ATP-dependent folding cycle. In yeast, CCT forms a ternary complex with the phosducin-like protein PLP2p to fold actin, and together they can return nascent or chemically denatured actin to its native state in a pure in vitro folding assay. The complexity of the CCT-actin system makes the study of the actin folding mechanism technically challenging. We have established a novel spectroscopic assay through selectively labeling the C-terminus of yeast actin with acrylodan and observe significant changes in the acrylodan fluorescence emission spectrum as actin is chemically unfolded and then refolded by the chaperonin. The variation in the polarity of the environment surrounding the fluorescent probe during the unfolding/folding processes has allowed us to monitor actin as it folds on CCT. The rate of actin folding at a range of temperatures and ATP concentrations has been determined for both wild type CCT and a mutant CCT, CCT4anc2 defective in folding actin in vivo. Binding of the non-hydrolysable ATP analogue AMP-PNP to the ternary complex leads to threefold faster release of actin from CCT following addition of ATP, suggesting a two-step folding process with a conformational change occurring upon closure of the cavity and a subsequent final folding step involving packing of the Cterminus to the native-like state.
Actin requires the chaperonin containing TCP1 (CCT), a hexadecameric ATPase essential for cell viability in eukaryotes, to fold to its native state. Following binding of unfolded actin to CCT, the cavity of the chaperone closes and actin is folded and released in an ATP-dependent folding cycle. In yeast, CCT forms a ternary complex with the phosducin-like protein PLP2p to fold actin, and together they can return nascent or chemically denatured actin to its native state in a pure in vitro folding assay. The complexity of the CCT-actin system makes the study of the actin folding mechanism technically challenging. We have established a novel spectroscopic assay through selectively labeling the C-terminus of yeast actin with acrylodan and observe significant changes in the acrylodan fluorescence emission spectrum as actin is chemically unfolded and then refolded by the chaperonin. The variation in the polarity of the environment surrounding the fluorescent probe during the unfolding/folding processes has allowed us to monitor actin as it folds on CCT. The rate of actin folding at a range of temperatures and ATP concentrations has been determined for both wild type CCT and a mutant CCT, CCT4anc2 defective in folding actin in vivo. Binding of the non-hydrolysable ATP analogue AMP-PNP to the ternary complex leads to threefold faster release of actin from CCT following addition of ATP, suggesting a two-step folding process with a conformational change occurring upon closure of the cavity and a subsequent final folding step involving packing of the Cterminus to the native-like state.
The cytoskeletal protein actin is one of the most highly conserved in all eukaryotes and is involved in many essential cellular processes such as cell motility and cytokinesis. It exists in two forms: at low ionic concentrations, the Gactin monomer is stable, whereas in the presence of KCl, MgCl 2 or CaCl 2 and ATP, the F-actin polymer predominates. The actin monomer consists of two domains, the so-called large domain and the small domain, which surround a nucleotide binding cleft and a high affinity divalent cation binding site (1) . Actin can be further divided into subdomains, with the N-and C-termini co-located at the base of subdomain 1 (Fig. 1) . G-actin can be unfolded thermally or chemically in the presence of denaturant or EDTA. Studies of the unfolding kinetics of rabbit skeletal muscle α-actin (ActA) with EDTA have shown that following loss of the cation and nucleotide from native actin, the actin then unfolds to an intermediate I 3 , which cannot refold spontaneously (2) (Eq. 1). Unfolding actin by EDTA treatment allows folding studies to be performed under physiological conditions. In eukaryotic cells, nascent actin is folded by the cytosolic chaperonin containing TCP1 (CCT or TRiC for TCP1-ring complex). CCT is a 1 MDa protein complex made up of two rings, each of which consists of 8 different subunits, known as CCTα -CCTθ in mammals and CCT1 -CCT8 in yeast. Recent studies of the CCT interactome have revealed a wide number of interacting proteins within the cell (3, 4) , although only a limited number of obligate substrates have been characterized, including actin and tubulin as well as a number of WD40 repeat containing proteins (5) . Actin folding by CCT in vivo in yeast requires the phosducin-like protein PLP2p (6), which contains a thioredoxin fold and forms a stable ternary structure with actin and CCT in vitro (7). The precise manner by which PLP2p assists actin folding is as yet unknown; PLP2p may be involved in the initial loading of actin onto CCT and ensuring that the correct engagement is reached, and/or it could have a role during folding or release. Although both EDTA-unfolded ActA and S. cerevisiae actin (Act1) can be bound by yeast CCT only Act1 can be productively refolded, indicating speciesspecific differences in actin folding behaviour and providing compelling evidence for the absolute dependence of actin on CCT for its folding to the native state (8) .
Here, we discuss the development of a spectroscopic actin folding assay which allows actin folding by CCT to be monitored in real time through labeling with the environmentally sensitive dye acrylodan. This approach allows greater sensitivity in the measurement of actin folding kinetics than gel electrophoresis-based assays, and has been used to observe the effects of ATP concentration and temperature on the rate of actin folding. Actin folding by CCT4anc2, a mutated form of CCT found in the temperature sensitive yeast strain anc2-1 (9), has also been investigated. We present evidence for an actin folding intermediate within a functional folding cycle.
EXPERIMENTAL PROCEDURES Purification and
Labeling of Act1-Act1 was purified from S. cerevisiae lysate by affinity chromatography using a DNase I-Affigel column followed by ion exchange chromatography (10) . The purified protein was eluted with approximately 220 mM KCl, and was polymerized by addition of 1 mM ATP and 2 mM MgCl 2 and incubation on ice for 30 min. A five-fold molar excess of Alexa Fluor 488-C 5 -maleimide (Invitrogen) or a twenty-fold molar excess of acrylodan (Anaspec) was added to the polymerized actin and incubated on ice overnight. The labeled actin was centrifuged (2 h, 4°C, 100 000 x g) then the pellet was resuspended in 10 mM Tris pH 7.5, 0.5 mM β-mercaptoethanol, 0.2 mM CaCl 2 , 50 μM ATP and dialyzed against the same buffer for 70 h at 4°C. After centrifugation, the supernatant was collected and the actin concentration and degree of labeling were calculated using the extinction coefficient 26 600 M After washing with His-Binding Buffer (50mM sodium phosphate pH 7.8, 300 mM NaCl, 10 mM imidazole, 0.03 % Triton X-100), PLP2p was eluted from the column with His-Elution Buffer (50mM sodium phosphate pH 7.8, 300 mM NaCl, 250 mM imidazole) and dialysed into 20mM HEPES pH 8, 75 mM KCl.
Polymerization of
Acryl Act1-Acryl Act1 (8.5 μM, 0.35 mg/ml) was incubated at room temperature in the presence of 100 mM KCl, 2 mM MgCl 2 , 1 mM ATP.
Unfolding of
Acryl Act1-Acryl Act1 was diluted in 20mM HEPES pH 8, 75 mM KCl, 1 mM TCEP, 2 μM ATP to concentrations of no more than 18 μg/ml (440 nM). Unfolding was carried out at 24°C by addition of 1.5 mM EDTA. 488 Act1 Folding Assay-488 Act1 (6.5 μg/ml, 160 nM) was unfolded in the presence of CCT (460 μg/ml, 460 nM) and PLP2p (15 μg/ml, 450 nM) in 20 mM HEPES pH 8, 75 mM KCl, 1 mM TCEP, 1.5 mM EDTA, 10 %v/v glycerol. Samples were protected from light and incubated at room temperature for 3 h. For release from CCT, 2 mM ATP and 10 mM MgCl 2 were added and the mixture was incubated at 30°C. Samples for gels were added to 20 mM HEPES pH 8, 10 %v/v glycerol, 1 mM CaCl 2 and kept on ice until loading onto a 6% native polyacrylamide gel containing 1 mM ATP. (7) Acryl Act Folding AssayAcryl Act1 or Acryl ActA (14.4 μg/ml, 350 nM) was unfolded for 3 h in the presence of CCT or CCT4anc2 (400 μg/ml, 400 nM) and PLP2p (13.5 μg/ml, 400 nM) as for 488 Act1. ATP and MgCl 2 were added so that the final concentrations were 1, 2 or 4 mM ATP, and 5, 10 or 20 mM MgCl 2 respectively, with the final glycerol concentration at 8 %v/v. Folding was monitored spectroscopically, either by repeatedly scanning the fluorescence emission of the sample or by monitoring emission at 470 nm for the duration of the reaction.
Co-polymerisation of 488 Act1 and

Acryl
Act1 with unlabeled Act1-Refolded Acryl Act1 or 488 Act1 was incubated overnight on ice with Act1 to a final Act1 concentration of 250 µg/ml (6 µM) in the presence of 115 mM KCl, 1.7 mM ATP and 6 mM MgCl 2 . After centrifugation (2 h, 4°C, 100 000 x g), the pellet was analysed by SDS PAGE.
AMP-PNP Actin Folding Assay-
Acryl Act1 or 488 Act1 were unfolded as described previously. Adenylyl imidodiphosphate (AMP-PNP) and MgCl 2 were added to final concentrations of 10 mM and 50 mM respectively, and samples were incubated at 30°C for 10 min. After this time, ATP or ADP and MgCl 2 were added so that the final concentrations were 8 mM AMP-PNP, 2 mM ATP or ADP, 50 mM MgCl 2 , 70 mM KCl, 8 %v/v glycerol, 0.64 mM TCEP and folding was monitored either spectroscopically for Acryl Act1 or by native PAGE for 488 Act1. Fluorescence measurements-Fluorescence emission was measured with the PTI QuantaMaster 40 spectrofluorometer with a Haake DC10-K15 refrigerated circulator attached. The excitation wavelength used was 380 nm, and the excitation slits were set to 2 nm. Emission spectra were collected from 425 -525 nm, and time-based emission was monitored at 470 nm with the emission slits set to 4 nm. Data Analysis-The change in the intensity of acrylodan fluorescence emission at 470 nm over time was fitted to a single exponential using GraphPad Prism 5 (GraphPad Software), with the first 50 seconds of time-based scans being excluded since a mixing phase could be seen. Rate constants were calculated as the mean of at least three independent experiments with error bars representing the standard deviation.
RESULTS
Acrylodan Labeling and Chemical Unfolding of
Act1. Dye labeling of Act1 at Cys374 has a large impact on the kinetics of chemical unfolding with EDTA, resulting in much more rapid unfolding of the labeled protein to the I 3 state in comparison to unlabeled Act1. This is a useful experimental property since yeast actin unfolds on a much slower time-scale than ActA, taking several hours to denature completely (2, 7). Actin was selectively labeled at Cys374 by polymerization followed by incubation with Alexa Fluor 488 or acrylodan, a thiol-reactive derivative of Prodan. Cys374 is located in a flexible stretch of residues at the C-terminus of actin which packs against subdomain 1 in the crystal structure of the actin-rhodamine dye complex (1) (Fig. 1) . Prodan, which has an emission maximum of 531 nm in water (13) , is highly sensitive to changes in its environment. In less polar solvents than water a blue shift in emission, accompanied by a large increase in the fluorescence intensity, occurs and this allows changes in the environment of the probe to be monitored spectroscopically. The emission of native acrylodan-labeled Act1 ( Acryl Act1 NAT ) is dramatically different to that of EDTA-unfolded Acryl Act1 ( Acryl Act1 I3 ), which has a very similar emission spectrum to CCT-bound Acryl Act1 (Fig.  2A) . The maximum emission wavelength for Acryl Act1 NAT is at 489 nm, and the Stokes shift of this form is 98 nm, in contrast to the EDTAunfolded protein which exhibits maximum fluorescence emission at 463 nm and has a Stokes shift of 81 nm. Interestingly, the maximum emission wavelength of the unfolded Acryl Act1 is very similar to the value of 465 nm reported for acrylodan-labeled rabbit skeletal muscle F-actin (14) , indicating that the environment in which the dye is found in F-actin is similar to that of the CCT-bound Acryl Act1. Within acrylodan-labeled yeast F-actin, fluorescence emission is also observed to be blue-shifted (Fig. 2B) , although not to the same extent as that of the acrylodan-labeled rabbit Factin (14) . This could reflect only partial incorporation of Acryl Act1 into the filaments, however it is known that actin labeled in this manner is capable of polymerisation since that is how it is purified. This blue shift in fluorescence emission in the unfolded, CCT-bound and polymerized Acryl Act1 indicates that the probe is in a less polar environment in all these three states compared to the native G-actin monomer. The rate of EDTA unfolding of Acryl Act1 NAT was determined by fitting a single exponential to the fluorescence emission at 470 nm (Fig. 2C) 488 Act1 can be released in the pure in vitro folding assay system (7) (Fig. 3A) . We then experimented with various environmentsensitive probes but found that some labeled actins behaved differently with respect to release from CCT; for example Act1, fluorescently labeled with 5-((2-((iodoacetyl)amino)ethyl)amino)naphthalene-1-sulfonic acid (IAEDANS), AEDANS Act1, could be loaded onto CCT, but native AEDANS Act1 could not be released from the complex (data not shown). In contrast, Acryl Act1 could be loaded onto CCT and released in the same manner as 488 Act1 (Fig. 3B) . It can be seen by native polyacrylamide gel electrophoresis (native PAGE) that the folding reaction is complete within approximately 10 minutes, and around 90 % of actin is released. The refolded Acryl Act1 can be bound by DNase I and vitamin D binding protein (VDBP) (Fig. 3B) , and copolymerized with unlabeled actin (Fig. 3D) , demonstrating that native G-actin is formed (7) . Further support for the natural behaviour of the folding system used here is that it is unable to fold Acryl ActA to the native state (Fig. 3C) . This had only previously been shown in the coupled IVT transcription/translation system (8) but is a property of this pure component system as well. Upon addition of ATP and MgCl 2 to the Acryl Act1-CCT-PLP2p complex, a decrease in acrylodan emission accompanied by a shift in the maximum emission wavelength is observed ( Fig. 2A and 4A) , thereby allowing the folding reaction to be monitored spectroscopically. This shift occurs over a similar time period to the release of native actin from CCT as observed by native PAGE, and as such can be used to make more accurate measurements of the rate of release from the chaperonin. A single exponential can be fitted to the decrease in emission as Acryl Act1 is released from CCT (Fig.  4A) . The observed rate constant of release (k) of Acryl Act1 from CCT over a range of temperatures was determined based on fluorescence emission at 470 nm. By fitting of these rate constants to the Arrhenius equation (Fig. 4B) , the activation energy of actin release by CCT was found to be 34 ± 8 kJ mol -1 , 32 ± 8 kJ mol -1 and 29 ± 19 kJ mol -1 for 4 mM, 2 mM and 1 mM ATP respectively. It can be seen that although both temperature and the concentration of ATP have an effect on the rate of release of Acryl Act1, the temperature dependence appears similar over the different ATP concentrations indicating that the reaction is proceeding by the same mechanism. The spectroscopic folding assay was not performed using 488 Act1 as only a very small change in the fluorescence emission is observed upon unfolding (2) and since a mixture of states exist during the folding process, the changes in intensity would be too small to accurately measure. Release of Act1 from CCT4anc2. CCT4anc2 contains the mutation G345D in subunit CCT4, located in the external region of the apical domain, and causes actin defects in the temperature sensitive yeast strain anc2-1 (9, 15) . Using the spectroscopic folding assay, the rate of release of Acryl Act1 by CCT4anc2 was found to be the same as for CCT at 2 mM ATP; however different behaviour was observed at the higher ATP concentration. At 4 mM ATP the rate of release of Acryl Act1, while faster than from the mutant at 2 mM ATP, was slower than that from wild-type CCT. Furthermore, the rate of release increased with temperature up to 32.5°C, but at temperatures above this there was a subsequent decrease in the rate of release (Fig. 5) , consistent with the heat-sensitive behaviour in vivo of CCT4anc2 mutant cells (9, 15) . Release of Act1 from CCT following addition of AMP-PNP. Addition of the non-hydrolysable ATP analogue AMP-PNP to CCT-bound Acryl Act1 had no significant effect on the acrylodan emission spectrum. However, upon addition of ATP to a final concentration of 2 mM, actin release could be seen to occur at a faster rate than observed when ATP was added directly to the Acryl Act1-CCT complex in the absence of AMP-PNP (Fig. 6A) . Fitting of a single exponential to the decrease in fluorescence gave an observed rate constant k of 11.8 x 10 -3 ± 0.7 x 10 -3 s -1 , which is an approximately three-fold increase relative to the release of Acryl Act1 from CCT without the preincubation step (3.8 x 10 -3 ± 0.3 x 10 -3 s -1 ). Following addition of ADP in place of ATP, no release was observed (Fig. 6A) . The same effect of pre-incubation of the loaded CCT complex with AMP-PNP was exhibited for release of 488 Act1 as demonstrated by native PAGE analysis (Fig. 6, B and C) , with virtually all 488 Act1 released from CCT and returned to its native state within 5 minutes of addition of ATP compared with 10 to 15 minutes with ATP alone.
DISCUSSION
Conformational changes at the C-terminus of actin during folding. The selective labeling of actin at its C-terminal cysteine is useful for observing changes in conformation of this flexible region of the protein. Labeling of Cys374 with bulky fluorophores has an effect on the local structure of the amino acid within the actin molecule (16) , with the label acting as a mutation which destabilizes the actin molecule sufficiently to allow chemical unfolding over a shorter time scale. It should be noted that chemically unfolded actin, not nascent actin, has been used in these assays, and the solution structures of these two denatured actin states, which are unknown, may well differ (12) . Nonetheless, binding of the fluorescently labeled actin to DNase I and VDBP and its ability to polymerize demonstrates that neither the introduction of the fluorophore, nor the manner of unfolding of actin, prevents folding of actin to a functional monomer. The proximity of the probe to the hinge region in the actin monomer makes it ideal for monitoring folding since EM structures demonstrate that actin bound to CCT takes on a more open structure, with the large and small domains binding in a 1,4 conformation across the cavity connected only by this hinge (17) . It has also been hypothesised that reconfiguration of the Cterminus is an important step in the chaperonemediated folding of actin (18) . The contribution of the C-terminus to the stability of Act1 is clearly reflected in the variability of folding and unfolding behaviours depending on the nature of modification at Cys374. The inability of CCT to refold AEDANS Act1, while 488 Act1 and Acryl Act1 can be refolded, demonstrates that the nature of the probe attached to the surface is very important and provides further evidence towards the role of the C-terminus both in the folding and the stability of native actin. Interestingly, the acrylodan moiety is located in a less polar environment in both the unfolded I 3 intermediate and in F-actin relative to G-actin. This demonstrates the differences in conformation between the monomeric and polymeric actin states, but also similarities between unfolded actin and F-actin. Perhaps Factin re-explores the unfolding landscape of actin during its functional cycles as proposed by Altschuler and Willison (19) . CCT subunits have been shown to associate with the F-actin filaments, which may indicate exposure of similar aggregation-prone, CCT-binding regions in both the unfolded and polymerized actin (20) . Actin Folding by CCT4anc2. The G345D mutation in CCT4anc2 affects the inter-ring allostery of the chaperonin, and results in a slower rate of ATP hydrolysis (15) . Actin folding by CCT4anc2 is defective in vivo above the permissive temperature of 30°C, with actin aggregates being observed in cells (9) . Folding assays with radiolabeled human β-actin demonstrated that while the rate of actin folding by CCT4anc2 is similar to that of wild-type CCT, there is an approximately two-fold reduction in the yield of native actin (15) . The data obtained from spectroscopic folding assay in general agrees with this, with the rate of actin release by the mutant affected by both changes in ATP concentration and temperature. A drop in the rate of actin release by CCT4anc2 is observed above the permissive temperature (highlighted in Fig. 5 ) and is more pronounced in the presence of 4 mM ATP compared to 2 mM ATP. We note that the intracellular concentrations of ATP in S. cerevisiae ranges from 1.1 to 4.5 mM (21) and therefore the maximum attainable level of activity of the enzyme may be being reached at 37°C in 4 mM ATP and hence the maximum effect of the anc2 mutation should be observed at these extremes (Fig. 5) . Nevertheless it is striking that the range of activity varies only two-fold over this physiological relevant range of both nucleotide concentration and temperature. A lower yield of native actin is observed in the presence of CCT4anc2 compared to with CCT (data not shown), but it is unclear whether this is due to a decrease in loading of the unfolded actin, less effective release from the chaperonin or a combination of the two. Mechanism of Actin Folding by CCT. The Cterminus of Act1 appears to be in a very similar environment in both the unfolded Acryl Act1 I3 and Acryl Act1-CCT based on the acrylodan emission spectra. This is the case for both the nucleotidefree and AMP-PNP bound Acryl Act1-CCT complexes, so it seems probable that no significant conformational rearrangement at the C-terminus of actin occurs upon binding of AMP-PNP and closure of the lid of the chaperonin (22) . The differing kinetics of ATPdependent release of native Acryl Act1 from CCT when pre-incubated with AMP-PNP relative to direct release from the complex indicates that a conformational change in actin does occur upon lid closure which corresponds to an initial folding step that is independent of the Cterminus of actin. Neirynck et al (18) developed a multi-step model for the CCT-mediated folding of human β-actin based on their analysis of mutants from an alanine scan of the entire actin polypeptide chain and previous structural electron microscopy models of CCT-actin complexes (17, 22) . Their model proposes two major transitions. During transition 1, the CCT-captured, extended form of actin rotates about the interdomain hinge region and rebinds as a more compact actin mass, as observed after closure of the CCT cavity by AMP-PNP (22) . During transition 2, the actin Cterminus which is still in direct contact with a CCT-subunit binding site, is released from CCT to establish its correct contacts with subdomain 1 of actin and this step completes folding. The kinetic behaviour of Acryl Act1 folding on CCT in the presence of AMP-PNP followed by ATP supports a sequential model of actin folding (Fig. 7) . Firstly, incubation of the pre-assembled CCT-actin-PLP2 ternary complex in AMP-PNP allows actin to progress along its folding trajectory to a more closed state, consistent with both the structural (22) and Förster resonance energy transfer studies (23) and secondly the addition of ATP permits the correct packing of the actin C-terminus and thus release. We suggest that an ATP hydrolysis step by a particular CCT subunit(s) is required for Cterminal release which is why AMP-PNP does not facilitate this process. The reduced polarity of the environment surrounding the probe in the Acryl Act1-CCT complex and the similarity of the emission spectra to that of acrylodan labeled rabbit F-actin (14) suggests that the C-terminus is unlikely to be 'free' in solution. Instead, it is likely to be fixed somewhere, probably on a particular CCT subunit binding site, and as such the acrylodan fluorescence remains unaffected by the preliminary folding step induced by binding of AMP-PNP. The acrylodan moiety could be tethered to CCT in this preliminary folding step, or bound to the actin molecule itself. This CCTactin folding intermediate complex can convert actin into its native form through rearrangement at the C-terminus of actin, perhaps locking the molecule into the correct conformation. This native or native-like conformation would be released from the post-ATP hydrolysis, ADP state of CCT which could no longer bind it as it was no longer in a non-native conformation. Based on the relative rates with or without preincubation with AMP-PNP, it appears that a slow rearrangement takes place upon binding of the nucleotide to CCT. This rearrangement does not include the labeled C-terminus, and most likely would be observed as a lag phase in the initial stages of the folding reaction which could well be masked in this analysis by the mixing period observed initially. Development of the spectroscopic folding assay for analysis by stopped flow might allow further insight into this stage of the reaction. This is followed by a more rapid rearrangement of the C-terminus as ATP is hydrolysed. The mechanism by which ATP displaces AMP-PNP in the chaperone complex is as yet unknown. Due to the variation in ATP binding sites across the subunits of CCT, it is possible that AMP-PNP is not bound at all the potential ATP binding sites within the chaperone. Binding and hydrolysis of ATP at an unoccupied site could then bring about the allosteric rearrangement required to instigate the final folding step and release of actin. Alternatively, the release process could be dependent on the dissociation rate of AMP-PNP and subsequent binding of ATP. The folding of actin by CCT is undoubtedly an intricate process and is likely to be composed of many further rearrangements before the native actin monomer can be released, and more work is required to characterize the elaborate folding pathway of actin and the contribution of cofactors such as PLP2. Here we have shown evidence that an actin folding intermediate can be trapped within a functional folding cycle, elucidating the importance of the packing of the C-terminal of actin as a final step in the folding process in order to ensure release of native actin from CCT. Fig. 1 . The crystal structure of G-actin (1), with ADP (light blue) and Ca 2+ (orange) bound. Actin is labelled at C374 with tetramethylrhodamine (purple). 
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